IP Library Granted Patent US 6,953,866
Granted Patent B2
US 6,953,866 · App. 10/769,365 · Granted Oct 11, 2005

Process for preparing ortho substituted phenylamines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,953,866
App. No.
10/769,365
Granted
Oct 11, 2005
Kind
B2
Abstract

A process is disclosed for preparing ortho substituted phenylamines comprising contacting phenylhydroxylamine, optionally substituted with at least one inert substituent, with a nucleophilic reagent in the presence of a manganese oxide at a temperature between about 10° C. and about 170° C. and a pressure from subatmospheric to superatmospheric such that an ortho substituted phenylamine, optionally correspondingly substituted with at least one inert substituent, is predominantly formed.

Claims (15)

1. A process of preparing ortho substituted phenylamines comprising contacting phenylhydroxylamine, optionally substituted with at least one inert substituent, with a nucleophilic reagent in the presence of a manganese oxide at a temperature between about 10° C. and about 170° C. and a pressure from subatmospheric to superatmospheric such that an ortho substituted phenylamine, optionally correspondingly substituted with at least one inert substituent, is formed.

2. The process of claim 1 wherein the phenylhydroxylamine is unsubstituted phenylhydroxylamine.

3. The process of claim 1 wherein the phenylhydroxylamine is substituted with at least one member selected from the group consisting of C 1 -C 10 alkyl, C 6 -C 10 aryl, and C 6 -C 10 alkaryl moieties.

4. The process of claim 1 wherein the nucleophilic reagent is selected from the group consisting of ammonia, water, C 1 -C 20 aliphatic alcohols, phenols, halides, and amines having the formula R′ 2 NH wherein each R′ may independently be a hydrogen, C 1 -C 20 aliphatic, C 4 -C 8 alicyclic, or C 6 -C 15 aryl or alkaryl moiety.

5. The process of claim 1 wherein the nucleophilic reagent is an amine represented by the formula R′ 2 NH wherein each R′ is independently a hydrogen, C 1 -C 5 alkyl, or C 6 -C 10 phenyl or alkyl-substituted phenyl moiety.

6. The process of claim 5 wherein the nucleophilic reagent is aniline.

7. The process of claim 1 wherein the molar ratio of nucleophilic reagent to phenylhydroxylamine ranges from about 2 to about 100.

8. A process for preparing ortho substituted phenylamines comprising contracting phenylhydroxylamine, optionally substituted with at least one inert substituent, with a nucleophilic reagent, the molar ratio of nucleophilic reagent to phenylhydroxylamine ranging from about 2 to about 100, the contacting of the phenylhydroxylamine and nucleophilic reagent being conducted in the absence of oxygen and in the presence of a catalyst that is a cryptomelane-type manganese oxide Octahedral Molecular Sieve, with a composition of KMn 8 O 16 .nH 2 O (n=0.5-10) in which said molecular sieve comprises MnO 6 octahedral structural units that are edge and corner shared to form a 4.6×4.6 tunnels as a result of 2×2 arrangement of octahedra, in which the potassium ions are present in the tunnels with water and said potassium ions are ion-exchanged by H + ions using nitric acid to obtain the acidic form of said sieve at temperatures ranging from about 70° C. to about 120° C., whereby an optionally-substituted ortho substituted phenylamine is formed.

9. The process of claim 8 wherein the phenylhydroxylamine is unsubstituted phenylhydroxylamine.

10. The process of claim 8 wherein the nucleophilic reagent is selected from the group consisting of ammonia, water, C 1 -C 20 aliphatic alcohols, phenols, halides, and amines having the formula R′ 2 NH wherein each R′ may independently be a hydrogen, C 1 -C 20 aliphatic, C 4 -C 8 alicyclic, or C 6 -C 15 aryl or alkaryl moiety.

11. The process of claim 8 wherein the nucleophilic reagent is aniline.

12. The process of claim 8 wherein the ortho substituted phenylamine is represented by the formula:

wherein R 2 is hydrogen or at least one C 1 -C 10 alkyl moiety, and X is selected from hydroxy, halo, C 1 -C 20 alkoxy, phenoxy, and amino of the formula —NR′ 2 wherein each R′ is independently a C 1 -C 20 aliphatic, C 4 -C 8 alicyclic, or C 6 -C 15 aryl or alkaryl moiety.

13. The process of claim 12 wherein X is amino and the ortho substituted phenylamine is a o-phenylenediamine.

14. The process of claim 13 wherein the ortho substituted phenylamine is o-aminodiphenylamine represented by the formula:

Assignments (3)
RELEASE OF SECURITY INTEREST RECORDED AT REEL 030872 FRAME 0810 Recorded Oct 16, 2018
From: WELLS FARGO BANK
To: ADDIVANT USA, LLC
Reel/Frame 047240/0580 →
RELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 11, 2017
From: BANK OF AMERICA, N.A.
To: CHEMTURA CORPORATION; BIOLAB FRANCHISE COMPANY, LLC; BIO-LAB, INC.; CROMPTON COLORS INCORPORATED; CROMPTON HOLDING CORPORATION; GLCC LAUREL, LLC; GREAT LAKES CHEMICAL CORPORATION; GREAT LAKES CHEMICAL GLOBAL, INC.; GT SEED TREATMENT, INC.; HOMECARE LABS, INC.; LAUREL INDUSTRIES HOLDINGS, INC.; RECREATIONAL WATER PRODUCTS, INC.; WEBER CITY ROAD LLC
Reel/Frame 042447/0508 →
RELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 11, 2017
From: BANK OF AMERICA, N.A.
To: CHEMTURA CORPORATION; BIOLAB FRANCHISE COMPANY, LLC; BIO-LAB, INC.; CROMPTON COLORS INCORPORATED; CROMPTON HOLDING CORPORATION; GLCC LAUREL, LLC; GREAT LAKES CHEMICAL CORPORATION; GREAT LAKES CHEMICAL GLOBAL, INC.; GT SEED TREATMENT, INC.; HOMECARE LABS, INC.; LAUREL INDUSTRIES HOLDINGS, INC.; RECREATIONAL WATER PRODUCTS, INC.; WEBER CITY ROAD LLC
Reel/Frame 042449/0001 →